Loading
Touyun Biotech Group Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$430.6M
1 insider bought shares over the last 90 days, the latest by Zhou RUIJUAN, filed 28 Sept 2026.
Touyun Biotech Group Ltd.: what insiders have been doing
Only a handful of insider records exist for Touyun Biotech Group Ltd., the last one from 28 September 2026, too few to describe a trend. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleZhou RUIJUAN1 buy
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.15
Analyst consensus
Income statement
Revenue-HK$5M
Gross profit-HK$54M1084% margin
EBITDAHK$92.4M-1856% margin
Net incomeHK$26.8M300.9% margin
Valuation
PER (trailing)2.1x
P/Book2.9x
Beta-0.66
Balance sheet & cash
Market capHK$430.6M
Total debtHK$413.6M
Free Cash Flow-HK$32.6M
Debt / Equity170%
Profitability & ownership
ROE197.4%
ROA-3.9%
% insiders42.1%
% institutions0.0%
Last declaration on 28 September 2026
Declarations1 total
28,000,000 sharesShareXHKGHKEX:DA20260928E00034
Canonical exit: 23 Dec 2026 (T+90)
1 of 1 declaration
About Touyun Biotech Group Ltd.
Touyun Biotech Group Ltd. is a company focused on the development and commercialization of biopharmaceutical products. It emphasizes innovation in biotechnology to enhance human health.